EDIT vs RUN
Editas Medicine Inc (EDIT) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
EDIT currently screens at market cap $375.2M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the EDIT and RUN stock pages for the full models.
Not investment advice.